바이오정보모아 (BioJungboMoa) — ADC · Antibody

8428프로그램 40FDA 승인

174오늘 방문

5,300누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대 Insight

High (injection of scAAV2-P1ND4v2 2.4 X10e10vg, injection of scAAV2-P1ND4v2 2.4 X10e10vg (High))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#인기#세포유전치료+4

효능 ORR 0.03%임상시험 61상태 ACTIVE

ADCBiologicstaleRelmada Therapeutics, Inc.deruxtecan improved objecti…Phase 2

Control treatment arm (Control treatment arm)

Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative) · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5

임상시험 61상태 RECRUITING

ADCBiologicchenxuPhase 2

Probiotic (Probiotic)

Muscle Invasive Bladder Cancer (MIBC) · Muscle Invasive Bladder Cancer (MIBC)

#MuscleInvasiveBladderCancerMIBC#ADC#Phase2#인기#항체약물접합체+3

임상시험 61상태 RECRUITING

ADCBiologicstaleHoffmann-La RochePhase 2

Empagliflozin (Empagliflozin)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+2

임상시험 61상태 RECRUITING

ADCBiologicstalePfizerPhase 2

Sunitinib Malate (Sunitinib Malate)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 59%임상시험 61상태 RECRUITING

ADCBiologicstaleRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+4

효능 ORR 77%임상시험 61상태 RECRUITING

CGTBiologicSanofiPhase 2

gemcitabin (gemcitabin)

Extranodal NK/T-cell Lymphoma, Nasal Type · Extranodal NK/T-cell Lymphoma, Nasal Typ

#ExtranodalNKT-cellLymphomaNasalT#CGT#Phase2#인기#세포유전치료+5

효능 ORR 32%임상시험 61상태 ACTIVE

AntibodystaleRochegovitecan in patients with …Phase 3

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody)

Bladder Cancer · Bladder Cancer

#BladderCancer#Antibody#Phase3#인기#항체+4

효능 ORR 75%임상시험 61상태 ACTIVE

ADCBiologicBristol-Myers SquibbreleasePhase 2

Taxane Chemotherapy (Taxane Chemotherapy)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 81.1%임상시험 61상태 RECRUITING

CGTBiologicstaleAstraZenecaPhase 2

Epidermal growth factor receptor (EGFRv, Epidermal growth factor receptor, Epidermal growth factor receptor(EGFRv)III Chimeric antigen receptor (CAR) transduced PBL)

Malignant Glioma; Glioblastoma · EGFR

#EGFR#CGT#Phase2#인기#세포유전치료+5

효능 ORR 68%임상시험 61상태 ACTIVE

ADCBiologicstaleBioMérieuxderuxtecan plus fluoropyrim…Phase 2

Experimental treatment arm (Experimental treatment arm)

Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative) · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5

임상시험 61상태 RECRUITING

ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 2

Hydroxydaunomycin (Hydroxydaunomycin)

Richter Syndrome; Chronic Lymphocytic Leukemia · Richter Syndrome

#RichterSyndrome#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 95%임상시험 61상태 RECRUITING

ADCBiologicstaleOHSU Knight Cancer InstitutePhase 1

Bicalutamide (Bicalutamide)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#인기#항체약물접합체+5

효능 ORR 19%임상시험 61상태 DISCONTINUED

ADCBiologicFondazione per la Medicina Pers…Phase 2

Oncology Drugs (Oncology Drugs)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+3

효능 ORR 37.5%임상시험 61상태 ACTIVE

ADCBiologicChipscreen Biosciences, Ltd.sPhase 3

taxane drug (taxane drug)

HER2-positive Metastatic Breast Cancer; First-line Treatment · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 81.1%임상시험 61상태 RECRUITING

CGTBiologicIstituto Clinico HumanitasPreclinical

immune evaluation (immune evaluation)

Oligorecurrent and Oligoprogressive Prostate Cancer Patients · Oligorecurrent and Oligoprogressive Pros

#OligorecurrentandOligoprogressiv#CGT#Preclinical#인기#세포유전치료+4

효능 ORR 37.5%임상시험 61상태 RECRUITING

CGTBiologicstaleiCell Gene TherapeuticsPhase 1

TCR (E6 T Cell Receptor, E6 T Cell Receptor (TCR))

Human Papillomavirus; HPV-16 · Human Papillomavirus

#HumanPapillomavirus#CGT#Phase1#인기#세포유전치료+5

효능 ORR 50%임상시험 61상태 DISCONTINUED

CGTBiologicByron LamPhase 1

Higher (injection of scAAV2-P1ND4v2 1.0 X10e11vg, injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#인기#세포유전치료+3

효능 ORR 0.03%임상시험 61상태 ACTIVE

ADCBiologicstaleMerck Sharp & Dohme LLCvedotin with dacarbazine or…Phase 2

DTIC (DTIC)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 96%임상시험 61상태 RECRUITING

ADCBiologicstaleEnyo PharmaPhase 2

B-CAP (B-CAP)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+3

효능 ORR 0.04%임상시험 61상태 ACTIVE

CGTBiologicstaleAlliance for Clinical Trials in…Phase 3

Allopurinol (Allopurinol)

B Acute Lymphoblastic Leukemia · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase3#인기#세포유전치료+5

임상시험 61상태 DISCONTINUED

CGTBiologicstaleGlaxoSmithKlineSN-38 also augmented IL-10 …Phase 2

topotecan hydrochloride (topotecan hydrochloride)

Fallopian Tube Carcinosarcoma; Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#인기#세포유전치료+5

효능 ORR 95.4%임상시험 61상태 DISCONTINUED

ADCBiologicstaleJohnson & Johnson Pharmaceutica…Phase 2

Epoetin Alfa (Epoetin Alfa)

Anemia; Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5

임상시험 61상태 RECRUITING

ADCBiologicstaleNovumvedotin, nivolumab, doxorub…Phase 3

Bleomycin Sulfate (Bleomycin Sulfate)

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 · Lugano Classification Limited Stage Hodg

#LuganoClassificationLimitedStage#ADC#Phase3#인기#항체약물접합체+4

효능 ORR 96%임상시험 61상태 RECRUITING

CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CAR-T cells (Autologous CAR-T cells)

Leukemia; Lymphoma · FRα

#FR#CGT#Phase2#인기#세포유전치료+5

효능 ORR 80.3%임상시험 61상태 ACTIVE

10 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 174 / 5,300

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

High (injection of scAAV2-P1ND4v2 2.4 X10e10vg, injection of scAAV2-P1ND4v2 2.4 X10e10vg (High))

Control treatment arm (Control treatment arm)

Probiotic (Probiotic)

Empagliflozin (Empagliflozin)

Sunitinib Malate (Sunitinib Malate)

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

gemcitabin (gemcitabin)

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody)

Taxane Chemotherapy (Taxane Chemotherapy)

Epidermal growth factor receptor (EGFRv, Epidermal growth factor receptor, Epidermal growth factor receptor(EGFRv)III Chimeric antigen receptor (CAR) transduced PBL)

Experimental treatment arm (Experimental treatment arm)

Hydroxydaunomycin (Hydroxydaunomycin)

Bicalutamide (Bicalutamide)

Oncology Drugs (Oncology Drugs)

taxane drug (taxane drug)

immune evaluation (immune evaluation)

TCR (E6 T Cell Receptor, E6 T Cell Receptor (TCR))

Higher (injection of scAAV2-P1ND4v2 1.0 X10e11vg, injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher))

DTIC (DTIC)

B-CAP (B-CAP)

Allopurinol (Allopurinol)

topotecan hydrochloride (topotecan hydrochloride)

Epoetin Alfa (Epoetin Alfa)

Bleomycin Sulfate (Bleomycin Sulfate)

Autologous CAR-T cells (Autologous CAR-T cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

High (injection of scAAV2-P1ND4v2 2.4 X10e10vg, injection of scAAV2-P1ND4v2 2.4 X10e10vg (High))

Control treatment arm (Control treatment arm)

Probiotic (Probiotic)

Empagliflozin (Empagliflozin)

Sunitinib Malate (Sunitinib Malate)

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

gemcitabin (gemcitabin)

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody)

Taxane Chemotherapy (Taxane Chemotherapy)

Epidermal growth factor receptor (EGFRv, Epidermal growth factor receptor, Epidermal growth factor receptor(EGFRv)III Chimeric antigen receptor (CAR) transduced PBL)

Experimental treatment arm (Experimental treatment arm)

Hydroxydaunomycin (Hydroxydaunomycin)

Bicalutamide (Bicalutamide)

Oncology Drugs (Oncology Drugs)

taxane drug (taxane drug)

immune evaluation (immune evaluation)

TCR (E6 T Cell Receptor, E6 T Cell Receptor (TCR))

Higher (injection of scAAV2-P1ND4v2 1.0 X10e11vg, injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher))

DTIC (DTIC)

B-CAP (B-CAP)

Allopurinol (Allopurinol)

topotecan hydrochloride (topotecan hydrochloride)

Epoetin Alfa (Epoetin Alfa)

Bleomycin Sulfate (Bleomycin Sulfate)

Autologous CAR-T cells (Autologous CAR-T cells)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

High (injection of scAAV2-P1ND4v2 2.4 X10e10vg, injection of scAAV2-P1ND4v2 2.4 X10e10vg (High))

Control treatment arm (Control treatment arm)

Probiotic (Probiotic)

Empagliflozin (Empagliflozin)

Sunitinib Malate (Sunitinib Malate)

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

gemcitabin (gemcitabin)

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody)

Taxane Chemotherapy (Taxane Chemotherapy)

Epidermal growth factor receptor (EGFRv, Epidermal growth factor receptor, Epidermal growth factor receptor(EGFRv)III Chimeric antigen receptor (CAR) transduced PBL)

Experimental treatment arm (Experimental treatment arm)

Hydroxydaunomycin (Hydroxydaunomycin)

Bicalutamide (Bicalutamide)

Oncology Drugs (Oncology Drugs)

taxane drug (taxane drug)

immune evaluation (immune evaluation)

TCR (E6 T Cell Receptor, E6 T Cell Receptor (TCR))

Higher (injection of scAAV2-P1ND4v2 1.0 X10e11vg, injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher))

DTIC (DTIC)